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INTRODUCTION
Peanut allergy patients have diverse clinical manifestations, 
depending on age, ethnicity, and sensitization profiles. In 
adults, sensitization and clinical patterns of peanut allergy are 
different from those in children.1,2 Peanut anaphylaxis (PA) is 
common in children; oral allergy syndrome (OAS) to peanut is 
common in adults. Cross-reactivity between Fagales tree (in-
cluding birch and oak family trees) pollen and peanut can ex-
plain the age difference observed in peanut allergy, as the Fag-
ales pollen sensitization rate increases with age.3 As some pa-
tients have both PA and OAS, accurate diagnosis of peanut al-
lergy and prediction of prognosis are important for these pa-
tients. 
In Asian populations, peanut allergic patients are rare com-
pared to those observed in Western countries.4 However, the in-
cidence of peanut allergy among Asian populations also con-
tinues to increase, though the precise cause of this phenome-
non is currently unknown.5,6 The increasing incidence of pea-
nut allergy in Korea may be due to increased Fagales sensitiza-
tion, which is cross-reactive to peanuts. The number of tree 
pollen-sensitized patients is increasing worldwide due to 
changes in atmospheric CO2, climate, and pollen counts;7 the 
incidence of Fagales pollen-related OAS is also increasing.8 In 
Korea, Fagales pollen sensitization is also increasing, which 
may be due to climate change and restoration of forests after 
the Korean War and the consecutive period of industrialization.
Differences in the sensitization to major peanut allergens 
have been reported in many previous studies. The Ara h 2 com-
ponent allergen is a storage protein in peanuts and well known 
to be suitable for diagnosing PA.9 However, OAS patients can 
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experience oral symptoms after peanut consumption; these 
cases are usually associated with Ara h 8, which belongs to the 
pathogenesis-related protein (PR)-10 family. The PR-10 family 
includes Bet v 1, Que a 1, Aln g 1, and Cor a 1. Furthermore, the 
sensitization patterns of peanut component allergens also dif-
fer among countries.10 
The aim of this study was to identify different sensitization 
patterns of birch and peanut component allergens associated 
with PA and OAS. These differences may enable physicians to 
accurately diagnose patients and to implement appropriate 
treatment plans for peanut allergy. In addition, diets and eating 
habits differ between Western and Eastern countries, and 
therefore, it is necessary to determine the patterns of OAS in 
East Asian countries.
MATERIALS AND METHODS
Study population
Birch pollen allergic patients (n=81) and PA patients (n=12) 
were retrospectively enrolled from January 2013 to June 2015 
from the Severance Resource Allergy Data System (Seoul, Ko-
rea), which includes clinical history, diagnosis, and sensitiza-
tion profiles of patients’ allergic diseases with their sera. Sensiti-
zation was determined using ImmunoCAP and skin prick test 
(SPT) results. Patients’ medical records were retrospectively re-
viewed for detailed clinical symptoms of cross-reactivity of food 
allergens to sensitized tree pollens.11 If the exact symptoms 
were not recorded, we conducted telephone interviews with 
the patients to obtain a more detailed clinical history. Based on 
the sensitization profiles and clinical manifestations, the pa-
tients were categorized into 4 groups. Group 1 included birch 
pollen allergic patients without OAS (patients with allergic rhi-
nitis or asthma); group 2 included birch pollen-related OAS pa-
tients; group 3 included patients with both OAS and PA; and 
group 4 included patients with PA but without OAS. Diagnosis 
of OAS and PA were determined by careful history taking, 
symptom reproducibility and sIgE titers. The classification of 
each group is shown schematically in Fig. 1. Sensitization pro-
files for birch and peanut were analyzed including component 
allergens. This study was approved by the Institutional Review 
Board of Yonsei University Health System (4-2013-0397). Par-
ticipating patients provided written informed consent. 
SPT
SPTs were performed on the patients’ backs using 55 kinds of 
allergens, including trees, grasses, weeds, molds, house dust 
mites, animal dander, white birch pollen, and white oak tree 
pollen (Allergopharma, Hamburg, Germany); a negative con-
trol (normal saline with 0.3% phenol and 50% glycerol) and 
positive control (0.1% histamine; Allergy Therapeutics, Worth-
ing, UK) were also tested. The SPT results were interpreted as 
positive if the wheal size of each allergen averaged ≥3 mm in 
diameter.
Serum allergen-specific immunoglobulin E measurement
Sera of the enrolled subjects, which were stored at -70°C, were 
used for IgE measurement. The ImmunoCAP system (Thermo 
Fisher, Uppsala, Sweden) was used to measure specific IgE 
(sIgE) to peanut and tree pollens. The total allergen and 5 re-
combinant component allergens (Ara h 1, Ara h 2, Ara h 3, Ara 
h 8, and Ara h 9) of peanuts were measured using the serum of 
each patient; sIgE titers ≥0.35 kU/L were considered positive. 
Titers >100 kU/L were regarded as 101 kU/L for statistical anal-
ysis. The levels of sIgE against the total birch and oak tree pol-
lens and component allergens of birch (Bet v 1, Bet v 2) were 
measured.
Statistical analysis
The data were analyzed using SPSS 18.0 (SPSS Inc., Chicago, 
IL, USA). Patients’ baseline characteristics were analyzed using 
Fisher’s exact, Pearson’s χ2, and Kruskal–Wallis tests. The posi-
tivity rate for each allergen was compared using Fisher’s exact 
or Pearson’s χ2 tests. The sIgE titers were compared with Mann-
Whitney U and Kruskal-Wallis tests. Dunn’s test was used for 
subgroup comparisons after the Kruskal-Wallis test. Receiver 
operating characteristic (ROC) curve analysis was performed to 
determine the sIgE cut-off titers for OAS. A comparison of the 
ROC curve was performed using MedCalc software (MedCalc, 
Mariakerke, Belgium). A P value of <0.05 was considered sta-
tistically significant.
RESULTS
Patients’ characteristics
The demographic characteristics of the enrolled patients are 
shown in Table 1. The mean age of the patients was 30.3 years. 
In Korea, PA in adults is rare, so that the mean age of group 4 
was 7.6 years. All the food allergy patients (groups 2, 3, and 4) 
re-experienced immediate allergic reactions by culprit food al-
lergen. The sex ratio was not different between groups. Total 
birch- sIgE level was highest in the OAS group (P=0.004), which 
was 2 times higher than in the non-OAS group. Initially, we 
Group 1
Fagales 
pollen allergy 
without OAS
Group 2
Fagales 
pollen allergy 
with OAS
Group 3
OAS with
peanut
anaphylaxis
Group 4
Peanut
anaphylaxis
Fagales pollen sensitizer
Fig. 1. Classification of participating patients into 4 groups. OAS, oral allergy 
syndrome.
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speculated that group 4 patients were not sensitized to birch. 
However, there were birch-sensitized patients (n=5, 62.5%) in 
group 4 as determined by the ImmunoCAP test. The total pea-
nut-sIgE level was highest in group 4 (P<0.001) and 3 times 
higher than in group 3. Clinical diagnosis and manifestations 
are also shown in Table 1. 
Clinical symptoms of OAS
In the OAS group (groups 2 and 3), apple was the most com-
mon cause of OAS, followed by peach, plum, and cherry in the 
Rosaceae family. Regarding the Fabaceae family, 18 patients 
(36.0%) experienced allergic reactions to peanuts, and 11 pa-
tients (22.0%) had reactions to legumes. With peanuts, 4 pa-
tients experienced anaphylaxis, while the others (n=14) experi-
enced only localized reactions. Four patients with both OAS 
and PA (group 3) experienced anaphylaxis after peanut con-
sumption, with localized oral symptoms after eating apples or 
peaches. The symptoms of OAS were limited to the mouth and 
oropharynx, and included an itching sensation, lip swelling, 
and erythematous changes. Patients commonly complained 
that the types of fruits that they were able to consume de-
creased with time. 
Interestingly, culprit foods associated with OAS in Korea are 
somewhat different from those in Westernized countries. We 
found a prevalence of OAS in patients with apple allergy that 
was similar to that reported in a previous study.12 However, 
none of the patients in our study had hazelnut allergy, which is 
not a popular food in Korea. Interestingly, 7 patients (14.0%) ex-
perienced oral symptoms after eating fresh Korean ginseng, a 
popular herbal medicine in Asia. Cherry, kiwi, chestnut, and 
ginseng showed similar allergic frequencies in the OAS group. 
The allergic response rate for different food types in OAS pa-
tients is shown in Table 2.
Sensitization profiles of peanut
The positivity rates of peanut and its component allergens are 
shown in Fig. 2A. The positive rate of the allergens was signifi-
cantly different between the groups. The positive rate of total 
peanut sIgE was 100% in the PA group (groups 3 and 4). In the 
OAS group, total peanut sIgE positivity was not correlated with 
symptoms. Interestingly, 19.2% of patients who had clinical 
symptoms to peanuts had a negative reaction to total peanut al-
lergens. 
The positivity rate to anaphylaxis-related component aller-
Table 1. Baseline characteristics of the patients
Parameters Total (n=93) Group 1 (n=35) Group 2 (n=46) Group 3 (n=4) Group 4 (n=8) P value*
Age (yr), Mean±SD 30.3±15.3 34.4±15.2 31.3±13.0 27.8±20.8 7.6±2.4 <0.001
Sex (M:F) 50:43 22:13 22:24 2:2 4:4 0.565
Specific IgE (kU/L), Mean±SD
   Birch 24.5±29.5 15.2±26.7 30.9±29.3 25.4±17.6 30.9±43.1 0.004
   Oak 11.8±20.8 15.5±16.5 20.3±15.7 20.3±15.7 25.3±38.7 0.115
   Peanut 3.9±11.2 1.2±2.0 0.9±1.2 10.9±17.6 29.5±24.8 <0.001
Diagnosis, N (%)
   Allergic rhinitis 84 (90.3) 33 (94.3) 44 (95.7) 4 (100) 3 (37.5) <0.001
   Asthma 25 (26.9) 13 (37.1) 10 (21.7) 0 (0) 2 (25) 0.303
   Oral allergy syndrome 50 (53.8) 0 (0) 46 (100) 4 (100) 0 (0) <0.001
   Food anaphylaxis 12 (12.9) 0 (0) 0 (0) 4 (100) 8 (100) <0.001
Reaction to peanut
   Localized symptoms 14 (15.1) 0 (0) 14 (30.3) 0 (0) 0 (0) <0.001
   Anaphylaxis 12 (12.9) 0 (0) 0 (0) 4 (100) 8 (100) <0.001
SD, standard deviation 
*P values were calculated using the Kruskal-Wallis test (age, specific IgE) and Fisher’s exact test (sex, diagnosis, reaction to peanut).
Table 2. Allergic response rates for each food in patients with oral allergy syn-
drome (n=50)
Culprit food Allergic response rate in OAS patients, N (%)
Rosaceae
   Apple 36 (72.0)
   Peach 33 (66.0)
   Plum 14 (28.0)
   Cherry 6 (12.0)
Fabaceae
   Peanut 18 (36.0)
   Legumes 11 (22.0)
Others
   Chestnut 8 (16.0)
   Kiwi 7 (14.0)
   Ginseng 7 (14.0)
OAS, oral allergy syndrome.
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gens (Ara h 1, Ara h 2, or Ara h 3) was 100% in group 4. In group 
4 patients, 7 out of 8 showed a positive response to Ara h 2. The 
remaining patient showed a positive response only to Ara h 1. 
Only 1 patient (1/12, 8.3%) in the PA group (groups 3 and 4) had 
no reaction to anaphylaxis-related component peanut aller-
gens. In the non-anaphylaxis group (group 1 and 2), there were 
3 (3.7%) patients who showed a positive response to Ara h 1, 
Ara h 2, or Ara h 3. Ara h 8 was highly positive in the OAS group 
(groups 2 or 3). In group 3, Ara h 2 showed 75% (3/4) positivity, 
and Ara h 8 showed 100% positivity. However, Ara h 8 positivity 
did not correlate with symptoms to peanut.
The sIgE titers of the 4 subgroups were also compared, and 
the results are shown in Fig. 2B. The total peanut sIgE titers 
were higher in the PA group than in the non-PA group. Similar 
patterns were found for Ara h 1, 2, and 3. These differences in 
total peanut allergens, Ara h 1, Ara h 2, and Ara h 3 were statisti-
cally significant. In contrast, Ara h 8-sIgE titers were highest in 
group 3, but there was no statistical significance. As mentioned 
earlier, 62.5% of group 4 patients were unexpectedly regarded 
as birch sensitizer. Ara h 9 was highly positive in group 3, but 
the titers were not significantly different between the groups. 
The mean titers of Ara h 9 in group 3 was 0.26±0.19 kU/L 
To demonstrate the sensitization profiles more clearly accord-
ing to the clinical manifestation, patients were divided into 2 
groups, depending on whether the symptom for peanut was 
OAS or PA. IgE positivity and titers are shown in Fig. 3A and B. 
PA patients showed the highest response to Ara h 2 (83.3%). 
Specific IgE titers to peanut, Ara h 1, Ara h 2, and Ara h 3 were 
higher in the anaphylaxis group than in the localized symptom 
group (P<0.001). Patients who had localized reactions to pea-
nut showed high positivity to Ara h 8. However, 75.0% (9/12) of 
patients in the PA group (groups 3 and 4) were also sensitized 
to birch pollen and 50.0% (6/12) to Ara h 8. For this reason, 
mean sIgE titers of Ara h 8 showed subtle difference between 
the groups (P=0.231). The positive rates of Ara h 3 and Ara h 9 
were not significantly different between the groups in the Kore-
an population. The sIgE titers of Ara h 9 was statistically differ-
ent ( Fig. 3B). However, the mean titers were 0.12 kU/L in the lo-
Fig. 2. Sensitization profiles of peanut allergens. (A) Positive rates, (B) Specific (IgE titers to total and component peanut allergens.
*P value<0.05; **P value<0.005.
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calized symptom group and 0.21 kU/L in the PA group.
Sensitization profiles of birch and oak pollen
Among all the participants, 63 (67.7%) underwent SPT. Among 
these participants, 82.5% and 82.5% were sensitized to birch and 
oak pollens, respectively. Alder pollen sensitization (86.7%) was 
found to have a pattern similar to that of birch and oak, and is 
known to be cross-reactive to birch tree pollen.13 When sensiti-
zation was based on ImmunoCAP results, which was performed 
iw n 90 patients (96.8%), 98.9% and 97.8% of the patients were 
sensitized to both birch and oak pollen, respectively. The per-
centages of positive responses to birch component allergens 
were 82.0% and 19.7% for Bet v 1 and Bet v 2, respectively. 
In order to show the sensitization patterns more specifically, 
birch-sensitized patients were divided into 2 groups: the non-
OAS group (groups 1 and 4) and the OAS group (groups 2 and 
3). Sensitization patterns are shown in Fig. 4. The sIgE titers of 
birch, oak, Bet v 1, and Ara h 8 were significantly higher in the 
OAS group than in the non-OAS group. Birch-sIgE titers of OAS 
patients were 1.7 times higher than thoseof non OAS patients. 
The sIgE titer of Bet v 1 was 2.4 times higher in OAS patients 
compared to nonOAS patients. The 2 component allergens Bet 
v 1 and Ara h 8 are belonged to the PR-10 family, and agree-
ment of the allergens was 93.8%. The sIgE titers of Bet v 2 were 
not different between the 2 groups, regardless of the presence 
of OAS symptoms. 
To predict OAS using sIgE titers, the ROC curve and optimal 
cutoff sIgE titer are shown in Fig. 5. Predictive abilities of OAS 
were not different between the sIgE titers for birch pollen, Bet v 
1, and Ara h 8. 
DISCUSSION
In this study, the sensitization patterns and clinical symptoms 
of patients with peanut and birch allergy were evaluated. Since 
tree pollen counts have increased over the past 15 years in Ko-
rea, the oak and birch tree sensitization rates have increased 
from 4.4% to 14.4%, and from 7.1% to 13.6%, respectively.14 Al-
though birch is not a dominant species in South Korea, there 
are many cross-reactive Fagaceae and Betulaceae family trees, 
including the Quercus and Alnus species.15 In Korea, Pinales 
(pine trees) and Fagales trees make up 80% of forests. Pine tree 
pollens are the most common in Korea, accounting for 70% of 
all tree pollens.16 Dominant Fagales trees in Korea include 
Quercus mongolica, Quercus serrata, Quercus aliena, and Quer-
cus acutissima. Choi et al.17 reported that as the temperature ris-
es, so does the proportion of Quercus species. Climate changes 
in Korea exceed the global climate change rate, especially with 
regard to temperature changes.18 Patients sensitized to tree pol-
len and those with OAS in Korea will be increasing due to this 
climate trend.  
Similar to Western countries, the incidence rates of peanut al-
lergy and sensitization are increasing in Korea. In this study, 
57.1% of patients in Korea with tree pollen allergy had total pea-
nut sIgE, regardless of symptoms. It is difficult to confirm pea-
nut allergy using the total peanut sIgE test. In this study, 19.2% 
of patients who exhibited symptoms in response to peanuts 
had a negative reaction to total peanut allergens. Total peanut 
sIgE is not enough to diagnose cross-reactive peanut allergy in 
those sensitized to Fagales. 
AUC 95% CI P value Cut-off sIgE titer Sensitivity Specificity
Birch 0.721 0.608 to 0.833 0.0001 >9.19 75.51 68.29
Oak 0.632 0.513 to 0.751 0.0292 >7.02 70.83 58.54
Bet v 1 0.768 0.645 to 0.892 <0.0001 >5.86 87.50 63.33
Ara h 8 0.698 0.570 to 0.825 0.0024 >0.33 82.98 60.00
Fig. 5. Receiver operating characteristic (ROC) curve of specific sIgE titers for 
prediction of oral allergy syndrome (OAS).
AUC, area under the curve; CI, confidence interval. 
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Sensitization profiles of peanut component allergens can be 
used for precise risk assessments and prediction of symptom 
severity. There have been many previous studies regarding re-
combinant peanut component allergens. When patients are co-
sensitized to Ara h 1, 2, and/or 3, they tend to experience severe 
allergic reactions to peanuts.19,20 Similar to a previous peanut 
component study, this study showed that Ara h 2 was positive 
in patients with PA, and that Ara h 8 was positive in those with 
localized symptoms. In patients with both PA and OAS, both 
Ara h 2 and Ara h 8 were positive. Among 12 PA patients, there 
was 1 patient (8.3%) who was only sensitized to Ara h 8 without 
Ara h 1, Ara h 2, or Ara h 3. (The patient was included in group 
3.)  In a previous Korean study, Ara h 2 was less prevalent than 
in Western countries.21 Large-scale research is needed to un-
derstand PA sensitization patterns in Korean patients. Based on 
our data, we were unable to clarify the order of sensitization be-
tween birch and peanut. Ara h 9, which belongs to a lipid trans-
fer protein, has limited clinical significance in Korea, but it is 
the most frequently sensitized peanut allergen in Mediterra-
nean countries (i.e., Spain), which suggests the possibility of 
cross-reactivity between the group 3 peach major allergen (Pru 
p 3) and Ara h 9.22 
Peanut component-resolved diagnosis can be used to dis-
criminate the cross-reaction to birch pollen and predict the se-
verity of peanut allergy.23 This precise diagnosis can lead to de-
creased unnecessary food elimination and medical costs. It 
may also play a role in discriminating between OAS patients 
with peanut allergy that may be treated by pollen-specific im-
munotherapy and patients with immunotherapy-intractable 
peanut allergies. According to our ROC evaluation, a cutoff val-
ue for birch or Bet v 1 can be applied to determine appropriate 
initiation timing of allergen immunotherapy. 
The sensitization patterns of Bet v 1 and 2 vary among coun-
tries.24 According to a previous study in Korea, the sensitization 
rates for Bet v 1 and 2 confirmed by an immunoblot were 78.9% 
and 75.8%, respectively.13 In this study, 82.0% and 19.7% of pa-
tients sensitized to birch pollen were Bet v 1- and v 2-positive, 
respectively. This difference can be explained by the use of dif-
ferent birch species and detection techniques. According to this 
study, Bet v 1 had more clinical implications compared to Bet v 
2. A higher titer of Bet v 1 better correlates with OAS symptoms. 
In addition, differences in the allergic response rate of various 
fruits in OAS patients should also be mentioned. Cross-reactive 
foods with tree pollen were somewhat different from that in 
Western countries. Apples or peaches were the most frequent 
causes of OAS in Korea. However, there were patients allergic to 
chestnuts and Korean ginseng. Ginseng is generally used as an 
herbal medicine in Asian countries. Currently, there is only 1 
published study about the cross-reactivity between Korean gin-
seng and birch pollens.25 Ginseng is available in fresh or dried 
forms and can be added to teas, alcoholic drinks, energy drinks, 
or skin cosmetics. Furthermore, it can be used for intravenous 
injection and acupuncture as a type of alternative medicine. 
When used as alternative medicine, patients can experience se-
vere allergic reactions after ginseng treatment. There have been 
2 case reports regarding ginseng-induced asthma and anaphy-
laxis; both patients were sensitized to the pollen of birch and al-
der trees.26,27 Clinicians should consider ginseng as a possible 
culprit for OAS. Chestnut allergy is common in latex-fruit aller-
gy patients.28 The biochemical classification of typical OAS 
(usually PR-10 related birch apple syndrome) is different from 
latex-fruit allergy (usually PR-3 related).29 Sensitization to pro-
filin (Bet v 2) has also been recognized to be important in the 
pathogenesis of OAS;22,30 however, Bet v 2 positivity was not cor-
related with clinical symptoms in our study. 
This study has certain limitations, namely its retrospective de-
sign. We could not directly compare changes in pollen count, 
sensitization rate, and peanut allergy incidence. In addition, the 
number of patients with PA was small. Furthermore, this re-
search was based on mainly adult patients. As the number of 
pediatric OAS patients is also increasing in Korea, additional re-
search including pediatric patients is needed. Further studies 
are needed to evaluate the efficacy of allergen immunotherapy 
using tree pollens as a treatment for peanut-related OAS pa-
tients. In some subgroups, patients with peanut allergy can be 
treated using immunotherapy. 
In conclusion, the increase in Fagales pollen allergy can influ-
ence the prevalence of peanut allergies. To discriminate be-
tween OAS involving peanut from vignette peanut allergy in 
Korea, it is crucial to measure component peanut allergens, es-
pecially Ara h 2 and Ara h 8.
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